Veeva Systems [VEEV] vs Ge Healthcare [GEHC] Detailed Stock Comparison
Veeva Systems
NYSE
Loading...
Ge Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Veeva Systems wins in 9 metrics, Ge Healthcare wins in 10 metrics, with 0 ties. Ge Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Veeva Systems | Ge Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 59.15 | 15.25 | Ge Healthcare |
| Price-to-Book Ratio | 7.33 | 3.50 | Ge Healthcare |
| Debt-to-Equity Ratio | 1.24 | 107.67 | Veeva Systems |
| PEG Ratio | 1.48 | 15.93 | Veeva Systems |
| EV/EBITDA | 48.88 | 11.04 | Ge Healthcare |
| Profit Margin (TTM) | 27.34% | 11.22% | Veeva Systems |
| Operating Margin (TTM) | 30.79% | 14.62% | Veeva Systems |
| EBITDA Margin (TTM) | 30.79% | 14.62% | Veeva Systems |
| Return on Equity | 14.06% | 25.80% | Ge Healthcare |
| Return on Assets (TTM) | 6.90% | 5.77% | Veeva Systems |
| Free Cash Flow (TTM) | $1.09B | $1.55B | Ge Healthcare |
| Dividend Yield | N/A | 0.24% | N/A |
| 1-Year Return | 45.77% | -13.44% | Veeva Systems |
| Price-to-Sales Ratio (TTM) | 15.98 | 1.70 | Ge Healthcare |
| Enterprise Value | $39.63B | $40.55B | Ge Healthcare |
| EV/Revenue Ratio | 13.88 | 2.03 | Ge Healthcare |
| Gross Profit Margin (TTM) | 77.10% | 39.65% | Veeva Systems |
| Revenue per Share (TTM) | $18 | $44 | Ge Healthcare |
| Earnings per Share (Diluted) | $4.72 | $4.88 | Ge Healthcare |
| Beta (Stock Volatility) | 0.96 | 1.28 | Veeva Systems |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Veeva Systems vs Ge Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Veeva Systems | 2.05% | -0.54% | 0.46% | 16.15% | 20.52% | 33.26% |
| Ge Healthcare | -0.35% | 1.94% | -1.33% | 0.67% | -20.79% | -6.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Veeva Systems | 45.77% | 28.01% | 5.12% | 1,057.15% | 532.15% | 532.15% |
| Ge Healthcare | -13.44% | 29.36% | 29.36% | 29.36% | 29.36% | 29.36% |
Performance & Financial Health Analysis: Veeva Systems vs Ge Healthcare
| Metric | VEEV | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $45.62B | $33.97B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,023,150 | 5,034,167 |
| 90 Day Avg. Volume | 1,195,860 | 3,925,566 |
| Last Close | $280.61 | $73.40 |
| 52 Week Range | $190.38 - $296.72 | $57.65 - $94.80 |
| % from 52W High | -5.43% | -22.57% |
| All-Time High | $343.96 (Aug 02, 2021) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -18.42% | -22.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.17% | 0.04% |
| Quarterly Earnings Growth | 0.41% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.27% | 0.11% |
| Operating Margin (TTM) | 0.31% | 0.15% |
| Return on Equity (TTM) | 0.14% | 0.26% |
| Debt to Equity (MRQ) | 1.24 | 107.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $38.11 | $21.27 |
| Cash per Share (MRQ) | $37.14 | $8.19 |
| Operating Cash Flow (TTM) | $1.20B | $2.00B |
| Levered Free Cash Flow (TTM) | $1.05B | $1.58B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.24% |
| Last 12-Month Dividend | N/A | $0.18 |
Valuation & Enterprise Metrics Analysis: Veeva Systems vs Ge Healthcare
| Metric | VEEV | GEHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 59.15 | 15.25 |
| Forward P/E | 41.30 | 15.93 |
| PEG Ratio | 1.48 | 15.93 |
| Price to Sales (TTM) | 15.98 | 1.70 |
| Price to Book (MRQ) | 7.33 | 3.50 |
| Market Capitalization | ||
| Market Capitalization | $45.62B | $33.97B |
| Enterprise Value | $39.63B | $40.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 13.88 | 2.03 |
| Enterprise to EBITDA | 48.88 | 11.04 |
| Risk & Other Metrics | ||
| Beta | 0.96 | 1.28 |
| Book Value per Share (MRQ) | $38.11 | $21.27 |
Financial Statements Comparison: Veeva Systems vs Ge Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VEEV | GEHC |
|---|---|---|
| Revenue/Sales | $759.04M | $4.78B |
| Cost of Goods Sold | $173.82M | $2.77B |
| Gross Profit | $585.22M | $2.01B |
| Research & Development | $184.03M | $344.00M |
| Operating Income (EBIT) | $233.73M | $628.00M |
| EBITDA | $243.55M | $842.00M |
| Pre-Tax Income | $298.82M | $692.00M |
| Income Tax | $70.63M | $104.00M |
| Net Income (Profit) | $228.19M | $588.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VEEV | GEHC |
|---|---|---|
| Cash & Equivalents | $1.96B | $2.45B |
| Total Current Assets | $6.71B | $9.74B |
| Total Current Liabilities | $1.46B | $9.97B |
| Long-Term Debt | $66.57M | $7.06B |
| Total Shareholders Equity | $6.21B | $9.42B |
| Retained Earnings | $3.68B | $3.81B |
| Property, Plant & Equipment | $122.23M | $369.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VEEV | GEHC |
|---|---|---|
| Operating Cash Flow | $810.54M | $509.00M |
| Capital Expenditures | N/A | $-152.00M |
| Free Cash Flow | $877.16M | $98.00M |
| Debt Repayment | N/A | $-257.00M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VEEV | GEHC |
|---|---|---|
| Shares Short | 4.62M | 9.02M |
| Short Ratio | 3.58 | 2.31 |
| Short % of Float | 0.03% | 0.03% |
| Average Daily Volume (10 Day) | 1,023,150 | 5,034,167 |
| Average Daily Volume (90 Day) | 1,195,860 | 3,925,566 |
| Shares Outstanding | 162.58M | 456.96M |
| Float Shares | 149.92M | 455.36M |
| % Held by Insiders | 0.09% | 0.00% |
| % Held by Institutions | 0.88% | 0.81% |
Dividend Analysis & Yield Comparison: Veeva Systems vs Ge Healthcare
| Metric | VEEV | GEHC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.18 |
| Last 12-Month Dividend Yield | N/A | 0.24% |
| 3-Year Avg Annual Dividend | N/A | $0.11 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | N/A | $0.33 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |